Last reviewed · How we verify
Isocapnic Oxygen
At a glance
| Generic name | Isocapnic Oxygen |
|---|---|
| Sponsor | University of Maryland, Baltimore |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Retinal Blood Flow and Autoregulation (PHASE4)
- Sex-related Differences in Sympathetic Vascular Transduction in the Setting of Hypoxemia (EARLY_PHASE1)
- Sex Disparities in Hypoxic Vasodilation and Impact of Obesity (EARLY_PHASE1)
- Characterizing Hypoxic Apnea Intra-individual Repeatability (NA)
- Sex Differences in Sympathetic Activity and Vascular Reactivity During Acute and Chronic Hypoxia. (NA)
- Iron Status and Hypoxic Pulmonary Vascular Responses (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Isocapnic Oxygen CI brief — competitive landscape report
- Isocapnic Oxygen updates RSS · CI watch RSS
- University of Maryland, Baltimore portfolio CI